Multiple initial culture conditions enhance the establishment of cell lines from primary ovarian cancer specimens (original) (raw)

References

• Arnold, N.; Hagele, L., Walz, L.; Schempp, W.; Pfisterer, J.; Bauknecht, T.; Kiechle, M. Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer. Genes Chromosomes Cancer 16: 46–54; 1996.
  Article PubMed CAS Google Scholar
• Cannistra, S. A. Cancer of the ovary. N. Engl. J. Med. 351: 2519–2529; 2004
  Article PubMed CAS Google Scholar
• Cannon, M. J.; Santin, A. D.; O'Brien, T. J. Immunological treatment of ovarian cancer. Curr. Opin. Obstet. Gynecol. 16: 87–92; 2004
  Article PubMed Google Scholar
• Cheng, K. W.; Lahad, J. P.; Kuo, W. L., et al. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat. Med. 10: 1251–1256; 2004.
  Article PubMed CAS Google Scholar
• Christianson, S. W.; Greiner, D. L.; Hesselton, R. A., et al. Enhanced human CD4+ T-cell engraftment in beta 2-microglobulin-deficient NOD-scid mice. J. Immunol. 158: 3578–3586; 1997.
  PubMed CAS Google Scholar
• Chu, P.; Wu, E.; Weiss, L. M. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: A survey of 435 cases. Mod. Pathol. 13: 962–972; 2000.
  Article PubMed CAS Google Scholar
• Freshney, R. I. Culture of animal cells: A manual of basic technique, 4th ed. New York: Wiley-Liss; 2000.
  Google Scholar
• Gazdar, A. F.; Oie, H. K. Re: Growth of cell lines and clinical specimens of human nonsmall-cell lung cancer in a serum-free-defined medium. Cancer Res. 46: 6011–6012; 1986.
  PubMed CAS Google Scholar
• Greshock, J.; Naylor, T. L.; Margolin, A., et al. 1-Mb resolution array-based comparative genomic hybridization using a BAC clone set optimized for cancer gene analysis. Genome Res. 14: 179–187; 2004.
  Article PubMed CAS Google Scholar
• Hellstrom, I.; Goodman, G.; Pullman, J.; Yang, Y.; Hellstrom, K. E. Over-expression of HER-2 in ovarian carcinomas. Cancer Res. 61: 2420–2423; 2001.
  PubMed CAS Google Scholar
• Hiorns, L. R.; Bradshaw, T. D.; Skelton, L. A.; Yu, Q.; Kelland, L. R.; Leyland-Jones, B. Variation in RNA expression and genomic DNA content acquired during cell culture. Br. J. Cancer 90: 476–482; 2004.
  Article PubMed CAS Google Scholar
• Hogdall, E. V.; Christensen, L.; Kjaer, S. K.; Blaakaer, J.; Bock, J. E.; Glud, E.; Norgaard-Pedersen, B.; Hogdall, C. K. Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: From the Danish MALOVA ovarian cancer study. Cancer 98: 66–73; 2003.
  Article PubMed CAS Google Scholar
• Hwu, P.; Freedman, R. S. The immunotherapy of patients with ovarian cancer. J. Immunother. 25: 189–201; 2002.
  Article PubMed CAS Google Scholar
• Iwabuchi, H.; Sakamoto, M.; Sakunaga, H.; Ma, Y. Y.; Carcangiu, M. L.; Pinkel, D.; Yang-Feng, T. L.; Gray, J. W. Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res. 55: 6172–6180; 1995.
  PubMed CAS Google Scholar
• Jemal, A.; Murray, T.; Ward, E.; Samuels, A.; Tiwari, R. C.; Ghafoor, A.; Feuer, E. J.; Thun, M. J. Cancer statistics, 2005. CA Cancer J. Clin. 55: 10–30; 2005.
  Article PubMed Google Scholar
• Kammerer, U.; Thanner, F.; Kapp, M.; Dietl, J.; Sutterlin, M. Expression of tumor markers on breast and ovarian cancer cell lines. Anticancer Res. 23: 1051–1055; 2003
  PubMed Google Scholar
• Kiechle, M.; Jacobsen, A.; Schwarz-Boeger, U.; Hedderich, J.; Pfisterer, J.; Arnold, N. Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation. Cancer 91: 534–540; 2001.
  Article PubMed CAS Google Scholar
• Lambros, M. B.; Fiegler, H.; Jones, A.; Gorman, P.; Roylance, R. R.; Carter, N. P.; Tomlinson, I. P. Analysis of ovarian cancer cell lines using array-based comparative genomic hybridization. J. Pathol. 205: 29–40; 2005.
  Article PubMed CAS Google Scholar
• Langdon, S. P. Isolation and culture of ovarian cancer cell lines. Methods Mol. Med. 88: 133–139; 2004.
  PubMed Google Scholar
• Latza, U., Niedobitek, G.; Schwarting, R.; Nekarda, H., and Stein, H. Ber-EP4. New monoclonal antibody, which distinguishes epithelia from mesothelial. J. Clin. Pathol. 43: 213–219; 1990.
  PubMed CAS Google Scholar
• MacLeod, R. A.; Dirks, W. G.; Matsuo, Y.; Kaufmann, M.; Milch, H.; Drexler, H. G. Widespread intraspecies crosscontamination of human tumor cell lines arising at source. Int. J. Cancer 83: 555–563; 1999.
  Article PubMed CAS Google Scholar
• Masters, J. R.; Thomson, J. A.; Daly-Burns, B., et al. Short tandem repeat profiling provides an international reference standard for human cell lines. Proc. Natl. Acad. Sci. USA 98: 8012–8017; 2001.
  Article PubMed CAS Google Scholar
• McCluggage, W. G. Recent advances in immunohistochemistry in gynecological pathology. Histopathology 40: 309–326; 2002.
  Article PubMed CAS Google Scholar
• Moll, R.; Franke, W. W.; Schiller, D. L.; Geiger, B.; Krepler, R. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors, and cultured cells. Cell 31: 11–24; 1982.
  Article PubMed CAS Google Scholar
• Orth, K.; Hung, J.; Gazdar, A.; Bowcock, A.; Mathis, J. M.; Sambrook, J. Genetic instability in human ovarian cancer cell lines. Proc. Natl. Acad. Sci. USA 91: 9495–9499; 1994.
  Article PubMed CAS Google Scholar
• Ozols R. F. Treatment goals in ovarian cancer. Int. J. Gynecol. Cancer 15 (Suppl. 1): 3–11; 2005.
  Article PubMed Google Scholar
• Platsoucas, C. D.; Fincke, J. E.; Pappas, J., et al. Immune responses to human tumors: Development of tumor vaccines. Anticancer Res. 23: 1969–1996; 2003.
  PubMed CAS Google Scholar
• Sato, E.; Olson, S. H.; Ahn, J., et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T-cell ratio are associated with favorable prognosis in ovarian cancer. Proc. Natl. Acad. Sci. USA 102: 18538–18543; 2005.
  Article PubMed CAS Google Scholar
• Schraml, P.; Schwerdtfeger, G.; Burkhalter, F., et al. Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5–q14 as a critical oncogene target in ovarian carcinoma. Am. J. Pathol. 163: 985–992; 2003.
  PubMed CAS Google Scholar
• Selvaggi, T. A.; Walker, R. E.; Fleisher, T. A. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 89: 776–779; 1997.
  PubMed CAS Google Scholar
• Shayesteh, L.; Lu, Y.; Kuo, W. L., et al. PIK3CA is implicated as an oncogene in ovarian cancer. Nat. Genet. 21: 99–102; 1999.
  Article PubMed CAS Google Scholar
• Shih, I.-E., Kurman, R. J. Ovarian tumorigenesis. A proposed model based on morphological and molecular analysis. Am. J. Pathol. 164: 1511–1518; 2004.
  PubMed CAS Google Scholar
• Sonoda, G.; Palazzo, J.; du Manoir S.; Godwin, A. K.; Feder, M.; Yakushiji, M.; Testa, J. R. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer 20: 320–328; 1997.
  Article PubMed CAS Google Scholar
• Stimpfl, M.; Schmid, B. C.; Schiebel, L.; Tong, D.; Leodolter, S.; Obermair, A.; Zeillinger, R. Expression of mucins and cytokerations in ovarian cancer cell lines. Cancer Lett. 145: 133–141; 1999.
  Article PubMed CAS Google Scholar
• Taub, R.; Kirsch, I.; Morton, C.; Lenoir, G.; Swan, D.; Tronick, S.; Aaronson, S.; Leder, P. Translation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc. Natl. Acad. Sci. USA 79: 7837–7841; 1982.
  Article PubMed CAS Google Scholar
• van den Berg-Bakker, C. A.; Hagemeijer, A.; Franken-Postma, E. M.; Smit, V. T.; Kuppen, P. J.; van Ravenswaay Claasen, H. H.; Cornelisse, C. J.; Schrier, P. I. Establishment and characterization of seven ovarian carcinoma cell lines and one granulosa tumor cell line: Growth features and cytogenetics. Int. J. Cancer 53: 613–620; 1993.
  Article PubMed Google Scholar
• Verschraegen, C. F.; Hu, W.; Du, Y., et al. Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic mullerian cancers. Clin. Cancer Res. 9: 845–852; 2003.
  PubMed CAS Google Scholar
• Ward, S.; Casey, D.; Labarthe, M. C.; Whelan, M.; Dalgleish, A.; Pandha, H.; Todryk, S. Immunotherapeutic potential of whole tumor cells. Cancer Immunol. Immunother. 51: 351–357; 2002.
  Article Google Scholar
• Watanabe, T.; Imoto, I.; Kosugi, Y.; Ishiwata, I.; Inoue, S.; Takayama, M.; Sato, A.; Inazawa, J. A novel amplification at 17q21–23 in ovarian cancer cell lines detected by comparative genomic hybridization. Gynecol. Oncol. 81: 172–177; 2001.
  Article PubMed CAS Google Scholar
• Wilson, A. P.; Garner C. M. Ovarian cancer. In: Maters, J.; Palsson, B. O., eds. Human cell culture: Volume II. Cancer cell lines part 2. London: Kluwer; 1999.
  Google Scholar
• Yin, B. W. T.; Lloyd, K. O. Molecular cloning of the CA125 ovarian cancer antigen. J. Biol. Chem. 276: 27371–27375; 2001.
  Article PubMed CAS Google Scholar
• Zhang, L.; Conejo-Garcia, J. R.; Katsaros, D., et al. Intratumoral T-cells, recurrence, and survival in epithelial ovarian cancer. N. Engl. J. Med. 348: 203–213; 2003.
  Article PubMed CAS Google Scholar

Download references